Author | Ryan McDonald


FDA’s Approval of Opdivo-Yervoy for Unresectable Malignant Pleural Mesothelioma was ‘Desperately Needed’, But Questions Remain

October 20, 2020

The FDA’s approval or Opdivo (nivolumab) and Yervoy (ipilimumab) for the frontline treatment of patients with unresectable malignant pleural mesothelioma was desperately needed, says a thoracic oncologist at Memorial Sloan Kettering Cancer center. However, some questions remain.

Friday Frontline: A Father Receiving Treatment for Leukemia Surprises His Daughter on Her Wedding Day; ‘The Wanted’ Singer Tom Parker Diagnosed with Inoperable Brain Tumor; and More

October 16, 2020

From “The Wanted” singer Tom Parker announcing he has been diagnosed with stage 4 glioblastoma and is undergoing treatment, to a Houston-area father receiving treatment for leukemia surprising his daughter on her wedding day, here’s what’s happening in the cancer landscape this week.

x